ADAM9 and posterior cortical atrophy: Among the four ADAM9 loci analyzed, we found that PCa patients carrying at least one minor allele (TG+GG) of rs6474526 had a significantly higher risk of developing advanced clinical T stages (cT3+4) (OR = 2.016, 95% CI = 1.101-3.690; p = 0.021) compared to those with the wild-type (WT) homozygote (TT), as shown in Table 4.